Trupanion (NASDAQ:TRUP) Downgraded to “Hold” Rating by Zacks Research

by · The Markets Daily

Trupanion (NASDAQ:TRUP – Get Free Report) was downgraded by research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Monday,Zacks.com reports.

Several other research analysts have also weighed in on TRUP. Stifel Nicolaus increased their target price on shares of Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a research note on Thursday, August 20th. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and set a $32.00 price objective on the stock. in a report on Wednesday. Weiss Ratings upgraded shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, August 12th. Finally, Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $39.20.

Check Out Our Latest Stock Analysis on Trupanion

Trupanion Stock Performance

Shares of Trupanion stock opened at $31.84 on Monday. Trupanion has a 52 week low of $21.16 and a 52 week high of $46.98. The business’s fifty day simple moving average is $26.63 and its 200-day simple moving average is $26.02. The firm has a market cap of $1.40 billion, a PE ratio of 60.08, a price-to-earnings-growth ratio of 2.15 and a beta of 1.39. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.

Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The company’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period last year, the company earned $0.22 EPS. Equities analysts forecast that Trupanion will post 0.63 earnings per share for the current year.

Insider Activity at Trupanion

In related news, CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90. Following the completion of the transaction, the chief executive officer directly owned 175,401 shares in the company, valued at $5,095,399.05. This trade represents a 0.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Steve Weinrauch sold 6,674 shares of Trupanion stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the completion of the transaction, the executive vice president directly owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. This represents a 7.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 12,117 shares of company stock worth $275,123 in the last three months. 5.58% of the stock is owned by company insiders.

Institutional Investors Weigh In On Trupanion

Large investors have recently added to or reduced their stakes in the business. Royal Bank of Canada boosted its position in Trupanion by 60.6% in the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock valued at $1,109,000 after buying an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Trupanion by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock worth $731,000 after acquiring an additional 858 shares during the period. Millennium Management LLC raised its stake in shares of Trupanion by 73.5% in the first quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after acquiring an additional 113,490 shares in the last quarter. Invesco Ltd. raised its stake in shares of Trupanion by 35.1% in the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after acquiring an additional 48,781 shares in the last quarter. Finally, Gabelli Funds LLC purchased a new position in Trupanion in the second quarter valued at $249,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.

Featured Articles